Arcus Biosciences
RCUS
RCUS
67 hedge funds and large institutions have $290M invested in Arcus Biosciences in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10.09% more ownership
Funds ownership: 50.47% → 60.56% (+10%)
7% less capital invested
Capital invested by funds: $313M → $290M (-$22.9M)
Holders
67
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$14.6M | |
| 2 | +$13.9M | |
| 3 | +$7.13M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.53M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.15M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$10.9M | |
| 3 | -$6.26M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$5.42M |
| 5 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
-$4.58M |